Status:
UNKNOWN
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women
Lead Sponsor:
New York Presbyterian Hospital
Conditions:
Breast Cancer
Eligibility:
FEMALE
30-75 years
Phase:
PHASE3
Brief Summary
The purpose of the study is to evaluate whether hCG will result in a decrease in breast density. High breast density has been associated with an increased risk in breast cancer. It has also been show...
Detailed Description
Pregnancy has been associated with a decreased risk of breast cancer. This has been reproduced in multiple studies and has been seen in multiple races. People have been evaluating different hormones ...
Eligibility Criteria
Inclusion
- On tamoxifen therapy for the treatment or prevention of breast cancer.
- Must have at least one remaining breast.
Exclusion
- Pregnant or nursing.
- No history of allergic reactions to hCG.
- Patients who have had bilateral mastectomies.
- Uncontrolled thyroid disease.
- Cognitively impaired and unable to consent for the trial.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT00808522
Start Date
December 1 2008
End Date
December 1 2009
Last Update
December 16 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Downtown Hospital
New York, New York, United States, 10038